Linying Huang

Jinan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

FOSL1 Orchestrates Epigenetic Reprogramming of Anaplastic Thyroid Cancer and Suppresses NK Cell-Mediated Antitumor Immunity.

FOSL1 Orchestrates Epigenetic Reprogramming of Anaplastic Thyroid Cancer and Suppresses NK Cell-Mediated Antitumor Immunity.

Journal: Cancer research
Published: June 29, 2025

Integrated functional genomics-identified DEAF1 in oxidative stress and hepatocellular carcinoma development.

Integrated functional genomics-identified DEAF1 in oxidative stress and hepatocellular carcinoma development.

Journal: Carcinogenesis
Published: January 13, 2025

MAZ promotes thyroid cancer progression by driving transcriptional reprogram and enhancing ERK1/2 activation.

MAZ promotes thyroid cancer progression by driving transcriptional reprogram and enhancing ERK1/2 activation.

Journal: Cancer letters
Published: June 19, 2024

The TDP-43/TP63 Positive Feedback Circuit Promotes Esophageal Squamous Cell Carcinoma Progression.

The TDP-43/TP63 Positive Feedback Circuit Promotes Esophageal Squamous Cell Carcinoma Progression.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 20, 2024

Genome-wide functional integration identified MAZ-controlled RPS14 dysregulation in hepatocellular carcinoma.

Genome-wide functional integration identified MAZ-controlled RPS14 dysregulation in hepatocellular carcinoma.

Journal: Archives of toxicology
Published: October 24, 2023

Super-enhancers: Implications in gastric cancer.

Super-enhancers: Implications in gastric cancer.

Journal: Mutation research. Reviews in mutation research
Published: September 21, 2023

Inflammatory cytokine-regulated LNCPTCTS suppresses thyroid cancer progression via enhancing Snail nuclear export.

Inflammatory cytokine-regulated LNCPTCTS suppresses thyroid cancer progression via enhancing Snail nuclear export.

Journal: Cancer letters
Published: July 20, 2023

Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer.

Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer.

Journal: Frontiers in cell and developmental biology
Published: May 22, 2023

The ASH1L-AS1-ASH1L axis controls NME1-mediated activation of the RAS signaling in gastric cancer.

The ASH1L-AS1-ASH1L axis controls NME1-mediated activation of the RAS signaling in gastric cancer.

Journal: Oncogene
Published: April 03, 2023

The Allelic Expression of RNA Editing Gene ADARB1 in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.

The Allelic Expression of RNA Editing Gene ADARB1 in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.

Journal: Pharmacogenomics and personalized medicine
Published: December 20, 2022

LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation.

LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation.

Journal: Cell reports
Published: October 05, 2022
Showing 1-11 of 11

Last Updated: 09/26/2026